Follow
Dilsa Mizrak Kaya
Dilsa Mizrak Kaya
MD Anderson Cancer Center, Houston, TX, USA
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
CD133:molecule of the moment
d mizrak, m alison
journal of pathology, 2008
7702008
Clinical Trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
R Idilman, D Mizrak
Alimentary Pharmacology & Therapeutics, 2008
1522008
Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis
G Yildiz, A Arslan-Ergul, S Bagislar, O Konu, H Yuzugullu, ...
PloS one 8 (5), e64016, 2013
682013
Global chemotherapy development for gastric cancer
K Harada, D Mizrak Kaya, Y Shimodaira, JA Ajani
Gastric Cancer 20, 92-101, 2017
422017
Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee …
A Alkan, ZG Guc, FC Senler, T Yavuzsen, H Onur, M Dogan, E Karci, ...
Supportive Care in Cancer 24, 3747-3755, 2016
342016
Liquid biopsies in gastrointestinal malignancies: when is the big day?
A Lopez, K Harada, D Mizrak Kaya, X Dong, S Song, JA Ajani
Expert review of anticancer therapy 18 (1), 19-38, 2018
312018
Advanced gastric adenocarcinoma: optimizing therapy options
D Mizrak Kaya, K Harada, Y Shimodaira, FG Amlashi, Q Lin, JA Ajani
Expert Review of Clinical Pharmacology 10 (3), 263-271, 2017
302017
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients
R Wadhwa, X Wang, V Baladandayuthapani, B Liu, H Shiozaki, ...
British Journal of Cancer 117 (5), 648-655, 2017
272017
A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease
M Sayki Arslan, S Turhan, I Dincer, D Mizrak, D Corapcioglu, R Idilman
Diabetology & metabolic syndrome 6, 1-6, 2014
212014
Aflatoxin exposure in viral hepatitis patients in Turkey
D Mizrak, B Engin, F ÖNDER, B Yener, M Bektaş, Z Biyikli, R Idilman, ...
Turkish Journal of Gastroenterology 20 (3), 2009
212009
İdilman R. Karaciğer nakli: hasta seçimi, gelişen endikasyonlar
D Mızrak
Turkiye Klinikleri J Gen Surg-Special Topics 2 (1), 10-3, 2009
202009
Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma
D Mizrak Kaya, GM Nogueras‐González, K Harada, FG Amlashi, ...
Journal of surgical oncology 117 (4), 678-684, 2018
182018
Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance
E Elimova, RS Slack, HC Chen, V Planjery, H Shiozaki, Y Shimodaira, ...
Oncotarget 8 (46), 81430, 2017
182017
101 long-term survivors who had metastatic gastroesophageal cancer and received local consolidative therapy
D Mizrak Kaya, X Wang, K Harada, MA Blum Murphy, P Das, BD Minsky, ...
Oncology 93 (4), 243-248, 2017
152017
Total lesion glycolysis assessment identifies a patient fraction with a high cure rate among esophageal adenocarcinoma patients treated with definitive chemoradiation
K Harada, CC Wu, X Wang, DM Kaya, FG Amlashi, M Iwatsuki, ...
Annals of surgery 272 (2), 311-318, 2020
132020
Early metabolic change after induction chemotherapy predicts histologic response and prognosis in patients with esophageal cancer: secondary analysis of a randomized trial
K Harada, X Wang, Y Shimodaira, T Sagebiel, MS Bhutani, JH Lee, ...
Targeted oncology 13, 99-106, 2018
132018
Metastatic gastroesophageal adenocarcinoma patients treated with systemic therapy followed by consolidative local therapy: a nomogram associated with long-term survivors
H Shiozaki, RS Slack, HC Chen, E Elimova, V Planjery, N Charalampakis, ...
Oncology 91 (1), 55-60, 2016
132016
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
Y Shimodaira, RS Slack, K Harada, HC Chen, T Sagebiel, MS Bhutani, ...
British journal of cancer 118 (3), 331-337, 2018
122018
Docetaxel-induced pericardial effusion
SE Dogan, D Mizrak, A Alkan, A Demirkazik
Journal of Oncology Pharmacy Practice 23 (5), 389-391, 2017
112017
Systemic immune-inflammation index as a prognostic marker of late recurrence in operable gastric cancer: a dual-center study
E Yekedüz, İ Dogan, DM Kaya, İ Özgür, G Utkan, S Vatansever, S Demirci, ...
Journal of Gastrointestinal Cancer, 1-10, 2022
102022
The system can't perform the operation now. Try again later.
Articles 1–20